Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Lundin, Catarina ^a,b   Forestier, Erik ^c   Klarskov Andersen, Mette ^d   Autio, Kirsi ^e   Barbany, Gisela ^f   Cavelier, Lucia ^g   Golovleva, Irina ^c   Heim, Sverre ^h   Heinonen, Kristiina ⁱ   Hovland, Randi ^j   Johannsson, Johann H ^k   Kjeldsen, Eigil ^l   Nordgren, Ann ^f   Palmqvist, Lars ^m   Johansson, Bertil ^a,b  

^a Department of Clinical Genetics University and Regional Laboratories Region Skåne ^*  (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d Rigshospitalet   (Denmark)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UPPSALA UNIVERSITY   (Sweden)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ ISLAB   (Finland)

^j HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^k LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^l AARHUS UNIVERSITY HOSPITAL   (Denmark)

^m SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

ALL; Children; Clinical features; Down syndrome; Genetic features; Prognosis

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; AGE DISTRIBUTION; ARTICLE; B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER PROGNOSIS; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME ABERRATION; CLINICAL FEATURE; CONTROLLED STUDY; DENMARK; DOWN SYNDROME; EVENT FREE SURVIVAL; FEMALE; FINLAND; GENETIC DIFFERENCE; HUMAN; ICELAND; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NORWAY; OVERALL SURVIVAL; SWEDEN; THROMBOCYTE COUNT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; DENMARK; DISEASE-FREE SURVIVAL; DOWN SYNDROME; FEMALE; FINLAND; HUMANS; ICELAND; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KARYOTYPE; KARYOTYPING; LEUKOCYTE COUNT; MALE; NORWAY; PLATELET COUNT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REGISTRIES; SWEDEN; TREATMENT OUTCOME;

EID: 84899990860     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-7-32     Document Type: Article

References (46)

1. Simultaneous occurrence of mongolism and leukemia: report of a nationwide survey. Krivit W, Good RA, AMA J Dis Child 1957 94 289 293
2. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Hasle H, Clemmensen IH, Mikkelsen M, Lancet 2000 355 165 169
3. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Lange B, Br J Haematol 2000 10 512 524
4. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J, Hovi L, Jonmundsson G, Lie SO, Glomstein A, Hasle H, Br J Haematol 2005 128 797 804
5. Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group. Maloney KW, Carroll WL, Carroll AJ, Devidas M, Borowitz MJ, Martin PL, Pullen J, Whitlock JA, Willman CL, Winick NJ, Camitta BM, Hunger SP, Blood 2010 116 1045 1050
6. Acute leukemias in children with Down syndrome. Seewald L, Taub JW, Maloney KW, McCabe ER, Mol Genet Metab 2012 107 25 30
7. Mortality and causes of death in persons with Down syndrome in California. Day SM, Strauss DJ, Shavelle RM, Reynolds RJ, Dev Med Child Neurol 2005 47 171 176
8. Down syndrome and acute leukemia in children: a 10-year retrospective survey from Childrens Cancer Study Group. Robison LL, Nesbit ME Jr, Sather HN, Level C, Shahidi N, Kennedy A, Hammond D, J Pediatr 1984 105 235 242
9. Prognosis of Down's syndrome with acute leukaemia. Levitt GA, Stiller CA, Chessells JM, Arch Dis Child 1990 65 212 216
10. Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Dördelmann M, Schrappe M, Reiter A, Zimmermann M, Graf N, Schott G, Lampert F, Harbott J, Niemeyer C, Ritter J, Dörffel W, Nessler G, Kühl J, Riehm H, Leukemia 1998 12 645 651
11. Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study. Whitlock JA, Sather HN, Gaynon P, Robison LL, Wells RJ, Trigg M, Heerema NA, Bhatia S, Blood 2005 106 4043 4049
12. Hematological abnormalities during the first week of life among neonates with Down syndrome: data from a multihospital healthcare system. Henry E, Walker D, Wiedmeier SE, Christensen RD, Am J Med Genet A 2007 143 42 50
13. Acute lymphoblastic leukaemia in children with Down syndrome: an updated review. Maloney KW, Br J Haematol 2011 155 420 425
14. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome. Roy A, Roberts I, Vyas P, Semin Fetal Neonatal Med 2012 17 196 201
15. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome. Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A, Shochat C, Cazzaniga G, Biondi A, Basso G, Cario G, Schrappe M, Stanulla M, Strehl S, Haas OA, Mann G, Binder V, Borkhardt A, Kempski H, Trka J, Bielorei B, Avigad S, Stark B, Smith O, Dastugue N, Bourquin JP, Tal NB, Green AR, Izraeli S, Lancet 2008 372 1484 1492
16. Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukaemia. Kearney L, Gonzalez De Castro D, Yeung J, Procter J, Horsley SW, Eguchi-Ishimae M, Bateman CM, Anderson K, Chaplin T, Young BD, Harrison CJ, Kempski H, So CWE, Ford AM, Greaves M, Blood 2009 113 646 648
17. Rearrangement of CRLF2 in B-progenitor and Down syndrome-associated acute lymphoblastic leukemia. Mullighan CG, Collins-Underwood JR, Phillips LAA, Loudin MG, Liu W, Zhang J, Ma J, Coustan-Smith E, Harvey RC, Willman CL, Mikhail FM, Meyer J, Carroll AJ, Williams RT, Cheng J, Heerema NA, Basso G, Pession A, Pui C-H, Raimondi SC, Hunger SP, Downing JR, Carroll WL, Rabin KR, Nat Genet 2009 41 1243 1246
18. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Russell LJ, Capasso M, Vater I, Akasaka T, Bernard OA, Calasanz MJ, Chandrasekaran T, Chapiro E, Gesk S, Griffiths M, Guttery DS, Haferlach C, Harder L, Heidenreich O, Irving J, Kearney L, Nguyen-Khac F, Machado L, Minto L, Majid A, Moorman AV, Morrison H, Rand V, Strefford JC, Schwab C, Tönnies H, Dyer MJS, Siebert R, Harrison CJ, Blood 2009 114 2688 2698
19. Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group study. Ragab AH, Abdel-Mageed A, Shuster JJ, Frankel LS, Pullen J, van Eys J, Sullivan MP, Boyett J, Borowitz M, Crist WM, Cancer 1991 67 1057 1063
20. Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia. Pui C-H, Raimondi SC, Borowitz MJ, Land VJ, Behm FG, Pullen DJ, Hancock ML, Shuster JJ, Steuber CP, Crist WM, Civin CI, Carroll AJ, J Clin Oncol 1993 11 1361 1367
21. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment. Chessells JM, Harrison G, Richards SM, Bailey CC, Hill FG, Gibson BE, Hann IM, Arch Dis Child 2001 85 321 325
22. Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray. Kawamata N, Ogawa S, Zimmermann M, Kato M, Sanada M, Hemminki K, Yamatomo G, Nannya Y, Koehler R, Flohr T, Miller CW, Harbott J, Ludwig W-D, Stanulla M, Schrappe M, Bartram CR, Koeffler HP, Blood 2008 111 776 784
23. Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Hertzberg L, Vendramini E, Ganmore I, Cazzaniga G, Schmitz M, Chalker J, Shiloh R, Iacobucci I, Shochat C, Zeligson S, Cario G, Stanulla M, Strehl S, Russell LJ, Harrison CJ, Bornhauser B, Yoda A, Rechavi G, Bercovich D, Borkhardt A, Kempski H, te Kronnie G, Bourquin J-P, Domany E, Izraeli S, Blood 2010 115 1006 1017
24. Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Loudin MG, Wang J, Eastwood Leung HC, Gurusiddappa S, Meyer J, Condos G, Morrison D, Tsimelzon A, Devidas M, Heerema NA, Carroll AJ, Plon SE, Hunger SP, Basso G, Pession A, Bhojwani D, Carroll WL, Rabin KR, Leukemia 2011 25 1555 1563
25. High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with Down syndrome. Lundin C, Hjorth L, Behrendtz M, Nordgren A, Palmqvist L, Andersen MK, Biloglav A, Forestier E, Paulsson K, Johansson B, Genes Chromosomes Cancer 2012 51 196 206
26. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Forestier E, Izraeli S, Beverloo B, Haas O, Pession A, Michalová K, Stark B, Harrison CJ, Teigler-Schlegel A, Johansson B, Blood 2008 111 1575 1583
27. High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols. Paulsson K, Forestier E, Andersen MK, Autio K, Barbany G, Borgström G, Cavelier L, Golovleva I, Heim S, Heinonen K, Hovland R, Johannsson JH, Kjeldsen E, Nordgren A, Palmqvist L, Johansson B, Haematologica 2013 98 1424 1432
28. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Buitenkamp TD, Izraeli S, Zimmermann M, Forestier E, Heerema NA, van den Heuvel-Eibrink MM, Pieters R, Korbijn CM, Silverman LB, Schmiegelow K, Liang DC, Horibe K, Arico M, Biondi A, Basso G, Rabin KR, Schrappe M, Cario G, Mann G, Morak M, Panzer-Grümayer R, Mondelaers V, Lammens T, Cavé H, Stark B, Ganmore I, Moorman AV, Vora A, Hunger SP, Pui CH, et al. Blood 2014 123 70 77
29. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Gustafsson G, Schmiegelow K, Forestier E, Clausen N, Glomstein A, Jonmundsson G, Mellander L, Makipernaa A, Nygaard R, Saarinen-Pihkala UM, Leukemia 2000 14 2267 2275
30. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Schmiegelow K, Forestier E, Hellebostad M, Heyman M, Kristinsson J, Söderhäll S, Taskinen M, Leukemia 2010 24 345 354
31. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Malinge S, Izraeli S, Crispino JD, Blood 2009 113 2619 2628
32. Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21. Roy A, Cowan G, Mead AJ, Filippi S, Bohn G, Chaidos A, Tunstall O, Chan JK, Choolani M, Bennett P, Kumar S, Atkinson D, Wyatt-Ashmead J, Hu M, Stumpf MP, Goudevenou K, O'Connor D, Chou ST, Weiss MJ, Karadimitris A, Jacobsen SE, Vyas P, Roberts I, Proc Natl Acad Sci U S A 2012 109 17579 17584
33. Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics group study. Harrison CJ, Moorman AV, Barber KE, Broadfield ZJ, Cheung KL, Harris RL, Jalali GR, Robinson HM, Strefford JC, Stewart A, Wright S, Griffiths M, Ross FM, Harewood H, Martineau M, Br J Haematol 2005 129 520 530
34. High hyperdiploid childhood acute lymphoblastic leukemia. Paulsson K, Johansson B, Genes Chromosomes Cancer 2009 48 637 660
35. Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Paulsson K, Forestier E, Lilljebjörn H, Heldrup J, Behrendtz M, Young BD, Johansson B, Proc Natl Acad Sci U S A 2010 107 21719 21724
36. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes). Heerema NA, Sather HN, Sensel MG, Zhang T, Hutchinson RJ, Nachman JB, Lange BJ, Steinherz PG, Bostrom BC, Reaman GH, Gaynon PS, Uckun FM, J Clin Oncol 2000 18 1876 1887
37. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21). Moorman AV, Richards SM, Robinson HM, Strefford JC, Gibson BES, Kinsey SE, Eden TOB, Vora AJ, Mitchell CD, Harrison CJ, Blood 2007 109 2327 2330
38. Two Down syndrome patients with an acquired translocation, t(8;14)(q11;q32), in early B-lineage acute lymphoblastic leukemia. Secker-Walker LM, Hawkins JM, Prentice HG, Mackie PH, Heerema NA, Provisor AJ, Cancer Genet Cytogenet 1993 70 148 150
39. B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome. Lundin C, Heldrup J, Ahlgren T, Olofsson T, Johansson B, Eur J Haematol 2009 82 46 53
40. Pediatric acute lymphoblastic leukemia with a t(8;14)(q11.2;q32): B-cell disease with a high proportion of Down syndrome: a Children's Oncology Group study. Messinger YH, Higgins RR, Devidas M, Hunger SP, Carroll AJ, Heerema NA, Cancer Genet 2012 205 453 458
41. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Arico M, Ziino O, Valsecchi MG, Cazzaniga G, Baronci C, Messina C, Pession A, Santoro N, Basso G, Conter V, Cancer 2008 113 515 521
42. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome. Meyr F, Escherich G, Mann G, Klingebiel T, Kulozik A, Rossig C, Schrappe M, Henze G, von Stackelberg A, Hitzler J, Br J Haematol 2013 162 98 106
43. Tumorigenesis in Down's syndrome: big lessons from a small chromosome. Nižetić D, Groet J, Nat Rev Cancer 2012 12 721 732
44. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome. Shah N, Al-Ahmari A, Al-Yamani A, Dupuis L, Stephens D, Hitzler J, Pediatr Blood Cancer 2009 52 14 19
45. Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia. Bohnstedt C, Levinsen M, Rosthøj S, Zeller B, Taskinen M, Hafsteinsdottir S, Bjö rgvinsdóttir H, Heyman M, Schmiegelow K, Leukemia 2013 27 866 870
46. Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol. Patrick K, Wade R, Goulden N, Rowntree C, Hough R, Moorman AV, Mitchell CD, Vora A, Br J Haematol in press